Sandoz Inc. vs. AbbVie Biotechnology Ltd
Explore the PTAB proceeding IPR2017-02106 filed by Sandoz Inc. on 2017-09-14. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-02106
Filing Date
2017-09-14
Accorded Filing Date
2017-09-14
Institution Decision Date
2018-04-03
Last Modified Date
2022-06-06
Proceeding Type
IPR
Termination Date
2018-11-02
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Sandoz Inc.
Represented By
Deborah FishmanPatent Owner / Respondent
AbbVie Biotechnology Ltd
Represented By
William B. RaichPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 36207 | Amy Mandragouras | +1 617-573-4700 |
| 36373 | Allan Brookes | +1 508-733-3757 |
| 36683 | Deann Smith | +1 617-832-1000 |
| 38327 | Peter Sullivan | +1 646-927-5510 |
| 40060 | John Lanza | +1 617-342-4084 |
| 42252 | Susan Abelleira | +1 617-832-1000 |
| 44075 | Portia Chen | +1 847-937-8272 |
| 44554 | Matthew Brady | +1 714-246-4788 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,067,992 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,085,620 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,090,689 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016037636 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,512,216 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019006241 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 68,164,505 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,715,664 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,808,700 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,906,373 B2 | US Continuation / Sibling | View Official Patent → |
Sandoz Inc. v. AbbVie Biotechnology Ltd et al.
Sandoz Inc. v. AbbVie Biotechnology Ltd
Sandoz Inc. v. AbbVie Biotechnology Ltd et al.